Motivation: Bipolar disorder (BD) and schizophrenia (SZ) has a difficult diagnosis, so the main objective of this article is to propose the use of Artificial Neural Networks (ANNs) to classify (diagnose) groups of patients with BD or SZ from a control group using sociodemographic and biochemical variables. Methods: Artificial neural networks are used as classifying tool. The data from this study were obtained from the array collection from Stanley Neuropathology Consortium databank. Inflammatory markers and characteristics of the sampled population were the inputs variables. Results: Our findings suggest that an artificial neural network could be trained with more than 90% accuracy, aiming the classification and diagnosis of bipolar, schizophrenia and control healthy group. Conclusion: Trained ANNs could be used to improve diagnosis in Schizophrenia and Bipolar disorders.
Introduction
Artificial neural network (ANN) attempts to use multiple layers of calculations to emulate the neuronal circuitry in the human brain by interpreting and drawing conclusions from several information. ANN algorithms are mathematical models based on biological neural systems that simulate the behavior of neurons.
The neuron receives inputs from multiple neurons and outputs a value based such as classification of breast cancer images and others, in prediction of heart disease, CD4+ T cell differentiation and immune cell subset classification, combining clinical predictors of antidepressant response in mood disorder, and other classifications [4] [5] .
Bipolar disorder (BD) and schizophrenia (SZ) are complex mental disorders with high genetic load, and are the largest global contributors to years with functional disability [6] . These disorders are among the most severe psychiatric disorders that affects around 1% and 0.8% of the general population, respectively [7] [8] [9] . BD is characterized by depressive, (hypo)manic, or mixed episodes [10] . SZ is characterized by amotivational, disorganized, affective, delusional, hallucinatory, or catatonic symptoms [10] . Both have been associated with negative health outcomes and progressive impairments [11] [12] . Therefore improve the diagnosis may be associated with a better definition of the treatment and lower damages to subject. Several evidences point out that psychiatric disorders have several changes in the molecular and functional mechanisms of the neuron, leading to observable changes in the brain [13] . Studies suggest that stressful events are important in the early stages of the disease [14] , so the phenotypic manifestation of mood disorders is presumably the result of the interaction between the effects of environmental stress and genetic predisposition.
BD and SZ have been associated with alteration in inflammatory cytokine levels, including Interleukin (IL-1, IL-6, IL-18, and IL-10), tumor necrosis factor alpha (TNF-α) and beta (TNF-β), transforming growth factor beta (TGF-β), and interferon gamma (IFNγ), when compared to healthy controls, and has been associated to neurotrophic factors changes [15] [16] [17] [18] [19] . These cytokines are produced by a variety of cell types including immune cells, muscular cells, glial cells and neurons; they mediate signaling between immune cells, and are mainly secreted from monocytes, macrophages or lymphocytes [20] . Moreover, cytokines play a central role in the control and modulation of inflammatory responses, and modulate the neurotrophins, with a constant balance between proinflammatory and anti-inflammatory cytokines [21] .
In the last years, there has been an upsurge of interest within the neuroscience community in the use of artificial intelligence (AI) methods, including ANN [22] [23] . Moreover, ANN analyses are gaining traction in psychiatric research, providing predictive models for both clinical practice and public health systems.
Compared with traditional statistical methods that provide primarily average group-level results, machine-learning algorithms provide predictions and stratification of clinical outcomes at the level of an individual subject [24] . However, for the best of our knowledge there is no ANN using an accessible peripheral 
Methods

Participants
The data from this study were obtained from the Array collection from Stanley Neuropathology Consortium databank (SNC) [25] [25] ). After all information was collected, the DSM-IV [10] psychiatric diagnosis was made independently by two senior psychiatrists. If there was disagreement between them, the records were made by a third senior psychiatrist.
Processing of Brain Tissue
Trained medical examiners collected and processed the brain tissue. Half of brain was fixed in formalin while the other is cut into 1.5 cm thick coronal slices and frozen in a mixture of isopentane and dry ice. The frozen half was stored at −70˚C until analysis.
Neuropathology Consortium
The Stanley Medical Research Institute (SMRI) [25] 
Multiplex Immunoassay Analysis
All analytes were measured by multiplex immunoassay. Extracts (200 µL) were analyzed using the Discovery MAP™ multiplexed immunoassay panel at Myriad-RBM (Austin, TX, USA). Each assay was calibrated using duplicate 8-point standard curves, and raw intensity measurements were interpreted into final protein concentrations using proprietary software. Machine performance was verified using quality control samples at low, medium, and high levels for each analyte [28] .
ANN Training and Statistical Analyses
In this study the inputs to the first layer of the neural network consist of 34 sociodemographic and biochemical variables while the target output consist of the following outputs trainings classifications: 1) control or case group; 2) control or BD group; 3) control or SZ group; and 4) BD or SZ group. The network is then trained to attempt to predict response from the set of variables. Supervised ANNs were applied in this work. Supervised ANNs means that the output is already know, in a training data bank. Supervised ANNs calculate an error function between the desired fixed output (target) and their own output, and adjust the connection strengths (weights) during the training process to minimize the result of the error function. The trained ANN can be seen as an equation, which translate the ANNs inputs into outputs, and rules by which the weights are modified to minimize the error of the equation [29] . A general ANN can be identified in Figure 1 , this topology has p inputs, one weight connected in each input, k neurons in parallel in a Hidden (or middle) layer, with a non-linear activation function, and one neuron in output layer, with linear activation function, for one output variable. This model of ANN can approximate the output of any continuous function [2] , and was used in this work to classify the diagnosis. To perform ANN training analyses, the OpenNN software was used. It is a multiplatform and open source software, for artificial neural networks [30] . In this work, the weights were randomized at the start of each training, and trained until the performance increase was above 1e-6 with the quasi-newton method. Also, the data bank was divided for training and testing, being 80% for training and 20% of the bank for test. The ANN training gives as result a confusion matrix. The accuracy, sensitivity, specificity and F1 score (harmonic mean between Figure 1 . Neural network representation with p inputs, k neurons in hidden (middle) layer and one output neuron for one output variable. Note that is possible to have p ≠ k, provided that each input has its weights. In this work we used 35 inputs (brain inflammatory markers and characteristics of the sampled population) and the output is binary as a classification of control group or BD or SZ disease. We vary the neurons in hidden layer to compare results and found the best suitable network. 
Results
The analysis was conducted with 104 data samples. The original data bank was Table 1 . In BD group, most subjects were female (67%) while in SZ and control groups were male (74% in both groups) (p = 0.025). 44% of BD patients and 20% of SZ patients are suicide victims, although there are no cases in control group (p ≤ 0.001). The mean age was 45.4 ± 10.67, 42.57 ± 8.47, and 44.2 ± 7.58 years for BD, SZ and control respectively. The duration of illness was 20.00 ± 9.62 and 21.29 ± 10.14 years for BD and SZ, respectively. In addition, the lifetime antipsychotics were 1.13 ± 2.62 and 9.70 ± 11.45 years for BD and SZ, respectively. Smoking data was also available, but due to the more than forty percent of missing values, these data was not take intoaccount at the training or in Table 1 score, sensitivity and specificity of this best case, using F1 score as tiebreaker when needed. ANN middle layer neurons were also compared from three to nine neurons. For less than three and more than nine neurons in ANN hidden layer, the accuracy results was below 50% (data not show).
A classification with cases and controls were performed. BD and SZ were grouped, (samples were randomly drawn to match the control group), in one patient cases group. An ANN training was done to classify cases and control groups. Results of these training can be seen in Table 2 . Results in Table 2 show the best achieved accuracy, F1 score, sensitivity and specificity; they were respectively 0.93, 0.95, 1.00 and 0.80 for three neurons.
For differentiation of BD from healthy people, ANN training results can be seen in Table 3 . One sample from control group was randomly drawn to match the BD group data sample. In Table 3 Schizophrenia patients group is differentiated from healthy group in Table 4 . 
Discussion
In present study was applied an ANN to discriminate two mental disorders and health subjects in clinical and inflammatory-based data. Regarding peripheral markers, there are still few studies that used AI techniques to identify biomarkers in patients with bipolar disorder or schizophrenia. A study by [35] was highlighted. The Space Vector Machine (SVM) algorithm differentiated patients with bipolar disorder from healthy controls with a predictive accuracy of 72.5%, and patients with schizophrenia from healthy subjects with a prediction accuracy of 77.5%. However, the algorithm was not able to differentiate patients with bipolar disorder from patients with schizophrenia (REF). In our study, although using a different technique, it found an accuracy of 92% when comparing patients with BD with healthy individuals, and 93% when we compared SZ with healthy individuals. Moreover, our findings differentiate patients with bipolar disorder from patients with schizophrenia; it was found an accuracy of 92%. It is necessary to point out that in the study of [35] ; the evaluations were carried out on blood samples, whereas the sample of this study was brain tissue. This is a study to evaluate the feasibility of using a biomarker tool developed with ANN algorithms to identify a patient with bipolar disorder or schizophrenia when compared to healthy controls. However, the present work has some limitations: 1) Our sample was small as we used a brain from post-mortem tissue; 2) the majority of individuals were taking medication, a factor that influences the results obtained. Despite these limitations, future studies should assess larger samples from multiple centers; use advanced mathematical techniques combined with other biological and clinical variables to improve our knowledge about schizophrenia and bipolar disorder. Moreover, in the last years the use of ANNs has been growing as to a promise approach in basic and clinical studies. Here, our findings suggest that artificial neural network could be valid to detect the role of markers in the involvement of inflammatory mechanisms in the pathophysiology of bipolar disorder and schizophrenia.
